Post-transplant lymphoproliferative disease (PTLD) is a group of disorders that may occur after transplantation. Its incidence is variable according to the transplanted organ. The clinical variability of this disease, its extra-nodal involvement and its broad histopathological spectrum make both classification and management very complex. This review provides an update about PTLD in patients with solid organ transplantation
Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially life-threatening compl...
International audiencePost-transplant lymphoproliferative disorders (PTLDs) represent a serious comp...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
Post-transplant lymphoproliferative disorders (PTLDs) occur as a consequence of immunosuppression in...
Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
Post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous set of complications of or...
SummaryPost-transplantation lymphoproliferative disorders (PTLDs) are heterogeneous lymphoid prolife...
Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoma, which develops as a result of imm...
Introduction Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of disease...
Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transp...
Post-transplant lymphoproliferative disease (PTLD) is a major complication after solid organ transpl...
Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of...
A joint working group established by the Haemato-oncology subgroup of the British Committee for Stan...
Post-transplant lymphoproliferative disease (PTLD) is a serious, often fatal complication after soli...
Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially life-threatening compl...
International audiencePost-transplant lymphoproliferative disorders (PTLDs) represent a serious comp...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
Post-transplant lymphoproliferative disorders (PTLDs) occur as a consequence of immunosuppression in...
Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
Post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous set of complications of or...
SummaryPost-transplantation lymphoproliferative disorders (PTLDs) are heterogeneous lymphoid prolife...
Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoma, which develops as a result of imm...
Introduction Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of disease...
Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transp...
Post-transplant lymphoproliferative disease (PTLD) is a major complication after solid organ transpl...
Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of...
A joint working group established by the Haemato-oncology subgroup of the British Committee for Stan...
Post-transplant lymphoproliferative disease (PTLD) is a serious, often fatal complication after soli...
Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially life-threatening compl...
International audiencePost-transplant lymphoproliferative disorders (PTLDs) represent a serious comp...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...